BioCentury | Jun 6, 2011
Company News
Mivac, Synthon deal
...with Mivac Development to research and develop multiple sclerosis (MS) candidates. The partners will use Mivac's...
...will develop and commercialize. Mivac is eligible for milestones and royalties. Details were not disclosed. Mivac Development AB...
...will develop and commercialize. Mivac is eligible for milestones and royalties. Details were not disclosed. Mivac Development AB...